The Link between Thyroid Function and Depression.
Mirella P. Hage,Sami T. Azar +1 more
TL;DR: Advances in biochemical, genetic, and neuroimaging fields have provided new insights into the thyroid-depression relationship and thyroid hormone supplements appear to accelerate and enhance the clinical response to antidepressant drugs.
read more
Abstract: The relation between thyroid function and depression has long been recognized. Patients with thyroid disorders are more prone to develop depressive symptoms and conversely depression may be accompanied by various subtle thyroid abnormalities. Traditionally, the most commonly documented abnormalities are elevated T4 levels, low T3, elevated rT3, a blunted TSH response to TRH, positive antithyroid antibodies, and elevated CSF TRH concentrations. In addition, thyroid hormone supplements appear to accelerate and enhance the clinical response to antidepressant drugs. However, the mechanisms underlying the interaction between thyroid function and depression remain to be further clarified. Recently, advances in biochemical, genetic, and neuroimaging fields have provided new insights into the thyroid-depression relationship.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
Gin S Malhi,Darryl Bassett,Philip Boyce,Richard A. Bryant,Paul B. Fitzgerald,Kristina Fritz,Malcolm Hopwood,Bill Lyndon,Roger T. Mulder,Greg Murray,Richard J Porter,Ajeet B. Singh +11 more
TL;DR: The Mood Disorder CPG is the first Clinical Practice Guideline to address both depressive and bipolar disorders and provides up-to-date recommendations and guidance within an evidence-based framework, supplemented by expert clinical consensus.
Depression and anxiety in patients with cancer
Alexandra Pitman,Sahil Suleman,Nicholas Hyde,Andrew Hodgkiss,Andrew Hodgkiss,Andrew Hodgkiss +5 more
TL;DR: The prevalence, aetiology, and management of depression and anxiety in patients with cancer is outlined to raise awareness among doctors of the need to address the psychiatric consequences of cancer.
Influence of maternal thyroid hormones during gestation on fetal brain development
Nora K. Moog,Sonja Entringer,Christine Heim,Pathik D. Wadhwa,Norbert Kathmann,Claudia Buss,Claudia Buss +6 more
TL;DR: Whether and how processes related to maternal stress and stress biology may interact with and modify the effects of maternal thyroid function on offspring brain development is considered, with implications for early identification of risk, primary prevention and intervention.
384
Biomarkers for depression: recent insights, current challenges and future prospects
TL;DR: A plethora of research has implicated hundreds of putative biomarkers for depression, but has not yet fully elucidated their roles in depressive illness or established what is abnormal in which patients and how biologic information can be used to enhance diagnosis, treatment and prognosis as mentioned in this paper.
Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model - are we there yet?
TL;DR: Environmental stressors and heritable genetic factors acting through immunologic and endocrine responses initiate structural and functional changes in many brain regions, resulting in dysfunctional neurogenesis and neurotransmission which then manifest as a constellation of symptoms which present as depression.
292
References
Neuroimaging studies of mood disorders.
TL;DR: Findings implicate interconnected neural circuits in which pathologic patterns of neurotransmission may result in the emotional, motivational, cognitive, and behavioral manifestations of primary and secondary affective disorders.
1.3K
Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment.
TL;DR: A synthesis of functional neuroimaging studies examining regional metabolic and blood flow changes in depression is presented in the context of a testable limbic-cortical network model, seen as a critical step towards future development of evidenced-based algorithms that will optimize the diagnosis and treatment of individual depressed patients.
American association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism
H. Jack Baskin,Rhoda H. Cobin,Daniel S. Duick,Hossein Gharib,Richard Guttler,Michael M. Kaplan,Robert L. Segal,Jeffrey R. Garber,Carlos R. Hamilton,Yehuda Handelsman,Richard Hellman,John S. Kukora,Philip T. Levy,Pasquale Palumbo,Steven M. Petak,Herbert I. Rettinger,Helena W. Rodbard,Talla P. Shankar,Sheldon S. Stoffer,John B Tourtelot +19 more
TL;DR: These clinical practice guidelines summarize the recommendations of the American Association of Clinical Endocrinologists for the diagnostic evaluation of hyperthyroidism and hypothyroidism, and for treatment strategies in patients with these disorders.
714
Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings.
Arthur L. Brody,Sanjaya Saxena,Paula Stoessel,Laurie A. Gillies,Lynn A. Fairbanks,Shervin Alborzian,Michael E. Phelps,Sung-Cheng Huang,Hsiao Ming Wu,Matthew L. Ho,Mai K. Ho,Scott C. Au,Karron M. Maidment,Lewis R. Baxter +13 more
TL;DR: In this paper, the authors examined baseline regional metabolic abnormalities and metabolic changes from pretreatment to post-treatment in subjects with major depressive disorder (MDD) and performed a preliminary comparison of regional changes with two distinct forms of treatment (paroxetine and interpersonal psychotherapy) and found that subjects with MDD had metabolic changes in the direction of normalization in these regions.
569